Anavex Life Sciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 18, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2016 - 2020
Market Capitalization	600	359	440	722	1,007	212	Upgrade
Market Cap Growth	103.28%	-18.30%	-39.06%	-28.30%	375.38%	56.56%	Upgrade
Enterprise Value	526	256	313	584	890	190	Upgrade
Last Close Price	7.05	4.19	5.38	9.52	13.01	2.30	Upgrade
PB Ratio	9.04	4.01	3.78	5.65	9.01	10.06	Upgrade
P/TBV Ratio	9.04	4.01	3.78	5.65	9.01	10.06	Upgrade
Quick Ratio	8.89	8.80	12.27	14.92	14.93	4.67	Upgrade
Current Ratio	8.93	8.86	12.32	14.95	14.97	4.73	Upgrade
Return on Equity (ROE)	-43.64%	-32.81%	-33.41%	-32.71%	-42.58%	-110.59%	Upgrade
Return on Assets (ROA)	-27.41%	-21.81%	-21.59%	-18.95%	-23.87%	-55.77%	Upgrade
Return on Capital (ROIC)	-30.30%	-24.12%	-23.32%	-20.31%	-26.29%	-70.26%	Upgrade
Earnings Yield	-5.86%	-8.93%	-8.85%	-5.96%	-2.79%	-9.60%	Upgrade
FCF Yield	-	-6.40%	-5.18%	-3.01%	-2.23%	-7.77%	Upgrade
Buyback Yield / Dilution	-2.72%	-4.61%	-3.74%	-10.18%	-19.95%	-18.99%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.